<VariationArchive VariationID="143485" VariationName="NM_001110792.2(MECP2):c.1490_1493del (p.Val497fs)" VariationType="Deletion" Accession="VCV000143485" Version="10" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-06-23" DateCreated="2015-04-24" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="153217" VariationID="143485">
      <GeneList>
        <Gene Symbol="MECP2" FullName="methyl-CpG binding protein 2" GeneID="4204" HGNC_ID="HGNC:6990" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154021573" stop="154097717" display_start="154021573" display_stop="154097717" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153287263" stop="153363187" display_start="153287263" display_stop="153363187" Strand="-" />
          </Location>
          <OMIM>300005</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001110792.2(MECP2):c.1490_1493del (p.Val497fs)</Name>
      <CanonicalSPDI>NC_000023.11:154030370:CTAACT:CT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154030371" stop="154030374" display_start="154030371" display_stop="154030374" variantLength="4" positionVCF="154030370" referenceAlleleVCF="GCTAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153295822" stop="153295825" display_start="153295822" display_stop="153295825" variantLength="4" positionVCF="153295821" referenceAlleleVCF="GCTAA" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>NM_001110792.2(MECP2):c.1490_1493del</Name>
        <Name>p.Val497fs</Name>
      </OtherNameList>
      <ProteinChange>V485fs</ProteinChange>
      <ProteinChange>V392fs</ProteinChange>
      <ProteinChange>V497fs</ProteinChange>
      <ProteinChange>V262fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004992.3" sequenceAccession="NM_004992" sequenceVersion="3" change="c.1454_1457delTTAG">
            <Expression>NM_004992.3:c.1454_1457delTTAG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="AJ132917.1" sequenceAccession="AJ132917" sequenceVersion="1" change="c.1454_1457del4">
            <Expression>AJ132917.1:c.1454_1457del4</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153295824_153295827del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153295824_153295827del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154030373_154030376del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154030373_154030376del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007107.3" sequenceAccession="NG_007107" sequenceVersion="3" change="g.111730_111733del">
            <Expression>NG_007107.3:g.111730_111733del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001110792.2" sequenceAccession="NM_001110792" sequenceVersion="2" change="c.1490_1493del" MANESelect="true">
            <Expression>NM_001110792.2:c.1490_1493del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001104262.1" sequenceAccession="NP_001104262" sequenceVersion="1" change="p.Val497fs">
            <Expression>NP_001104262.1:p.Val497fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316337.2" sequenceAccession="NM_001316337" sequenceVersion="2" change="c.1175_1178del">
            <Expression>NM_001316337.2:c.1175_1178del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001303266.1" sequenceAccession="NP_001303266" sequenceVersion="1" change="p.Val392fs">
            <Expression>NP_001303266.1:p.Val392fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369391.2" sequenceAccession="NM_001369391" sequenceVersion="2" change="c.1175_1178del">
            <Expression>NM_001369391.2:c.1175_1178del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356320.1" sequenceAccession="NP_001356320" sequenceVersion="1" change="p.Val392fs">
            <Expression>NP_001356320.1:p.Val392fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369392.2" sequenceAccession="NM_001369392" sequenceVersion="2" change="c.1175_1178del">
            <Expression>NM_001369392.2:c.1175_1178del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356321.1" sequenceAccession="NP_001356321" sequenceVersion="1" change="p.Val392fs">
            <Expression>NP_001356321.1:p.Val392fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369393.2" sequenceAccession="NM_001369393" sequenceVersion="2" change="c.1175_1178del">
            <Expression>NM_001369393.2:c.1175_1178del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356322.1" sequenceAccession="NP_001356322" sequenceVersion="1" change="p.Val392fs">
            <Expression>NP_001356322.1:p.Val392fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369394.2" sequenceAccession="NM_001369394" sequenceVersion="2" change="c.1175_1178del">
            <Expression>NM_001369394.2:c.1175_1178del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356323.1" sequenceAccession="NP_001356323" sequenceVersion="1" change="p.Val392fs">
            <Expression>NP_001356323.1:p.Val392fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386137.1" sequenceAccession="NM_001386137" sequenceVersion="1" change="c.785_788del">
            <Expression>NM_001386137.1:c.785_788del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373066.1" sequenceAccession="NP_001373066" sequenceVersion="1" change="p.Val262fs">
            <Expression>NP_001373066.1:p.Val262fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386138.1" sequenceAccession="NM_001386138" sequenceVersion="1" change="c.785_788del">
            <Expression>NM_001386138.1:c.785_788del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373067.1" sequenceAccession="NP_001373067" sequenceVersion="1" change="p.Val262fs">
            <Expression>NP_001373067.1:p.Val262fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386139.1" sequenceAccession="NM_001386139" sequenceVersion="1" change="c.785_788del">
            <Expression>NM_001386139.1:c.785_788del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373068.1" sequenceAccession="NP_001373068" sequenceVersion="1" change="p.Val262fs">
            <Expression>NP_001373068.1:p.Val262fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004992.4" sequenceAccession="NM_004992" sequenceVersion="4" change="c.1454_1457del" MANEPlusClinical="true">
            <Expression>NM_004992.4:c.1454_1457del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004983.1" sequenceAccession="NP_004983" sequenceVersion="1" change="p.Val485fs">
            <Expression>NP_004983.1:p.Val485fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_764" sequenceAccession="LRG_764">
            <Expression>LRG_764:g.111730_111733del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_764t1" sequenceAccession="LRG_764t1">
            <Expression>LRG_764t1:c.1490_1493del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_764p1" sequenceAccession="LRG_764p1" change="p.Val497fs">
            <Expression>LRG_764p1:p.Val497fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_764t2" sequenceAccession="LRG_764t2">
            <Expression>LRG_764t2:c.1454_1457del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_764p2" sequenceAccession="LRG_764p2" change="p.Val485fs">
            <Expression>LRG_764p2:p.Val485fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA273848" DB="ClinGen" />
        <XRef Type="rs" ID="267608640" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1490_1493del (p.Val497fs) AND Rett syndrome" Accession="RCV000168709" Version="8">
        <ClassifiedConditionList TraitSetID="3215">
          <ClassifiedCondition DB="MedGen" ID="C0035372">Rett syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-05-10" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001110792.2(MECP2):c.1490_1493del (p.Val497fs) AND Severe neonatal-onset encephalopathy with microcephaly" Accession="RCV001042819" Version="6">
        <ClassifiedConditionList TraitSetID="6528">
          <ClassifiedCondition DB="MedGen" ID="C1968556">Severe neonatal-onset encephalopathy with microcephaly</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-10" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2015-04-24" MostRecentSubmission="2024-02-28">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11402105</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16473305</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20108430</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/2b25a547-31cf-4986-8974-e84c38965b32</URL>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/59542a41-0c1c-47cb-8ce1-4e85f89f2ae4</URL>
        </Citation>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-03">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6528" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1150" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, neonatal severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe neonatal-onset encephalopathy with microcephaly</ElementValue>
                <XRef ID="MONDO:0010397" DB="MONDO" />
                <XRef ID="209370" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, neonatal severe, due to MECP2 mutations</ElementValue>
                <XRef ID="Encephalopathy%2C+neonatal+severe%2C+due+to+MECP2+mutations/8310" DB="Genetic Alliance" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="Genetics Home Reference (GHR) links">MECP2-related severe neonatal encephalopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17103" />
                <XRef ID="17103" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MECP2-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MECP2-Related Severe Neonatal Encephalopathy</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301670</ID>
                <ID Source="BookShelf">NBK1497</ID>
              </Citation>
              <XRef ID="209370" DB="Orphanet" />
              <XRef ID="C1968556" DB="MedGen" />
              <XRef ID="MONDO:0010397" DB="MONDO" />
              <XRef Type="MIM" ID="300673" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3215" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3622" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rett syndrome</ElementValue>
                <XRef ID="MONDO:0010726" DB="MONDO" />
                <XRef ID="778" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autism, dementia, ataxia, and loss of purposeful hand use</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rett's disorder</ElementValue>
                <XRef ID="Rett+syndrome/6294" DB="Genetic Alliance" />
                <XRef ID="68618008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RTT</ElementValue>
                <XRef Type="MIM" ID="312750" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RTS</ElementValue>
                <XRef Type="MIM" ID="312750" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5696" />
                <XRef ID="5696" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MECP2-Related Disorders</Attribute>
                <XRef ID="NBK1497" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301670</ID>
                <ID Source="BookShelf">NBK1497</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111012</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <XRef ID="3095" DB="Orphanet" />
              <XRef ID="778" DB="Orphanet" />
              <XRef ID="C0035372" DB="MedGen" />
              <XRef ID="MONDO:0010726" DB="MONDO" />
              <XRef Type="MIM" ID="312750" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="310803" SubmissionDate="2014-11-21" DateLastUpdated="2015-04-24" DateCreated="2014-08-17">
        <ClinVarSubmissionID localKey="MC221" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000188003" DateUpdated="2015-04-24" DateCreated="2014-08-17" Type="SCV" Version="2" SubmitterName="RettBASE" OrgID="504290" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-01-21">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <Citation>
              <ID Source="PubMed">11402105</ID>
            </Citation>
            <Comment>Rett syndrome - Not certain</Comment>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Tissue>blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <Citation>
              <ID Source="PubMed">16473305</ID>
            </Citation>
            <Comment>Rett syndrome - not certain</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004992.3:c.1454_1457del4</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Rett syndrome</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="312750" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>CHWRETT_2012_1_30</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="4970145" SubmissionDate="2022-06-30" DateLastUpdated="2022-07-09" DateCreated="2022-07-09">
        <ClinVarSubmissionID localKey="59542a41-0c1c-47cb-8ce1-4e85f89f2ae4" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002540721" DateUpdated="2022-07-09" DateCreated="2022-07-09" Type="SCV" Version="1" SubmitterName="ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel" OrgID="508065" OrganizationCategory="consortium" OrgAbbreviation="Rett/AS VCEP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-10">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/59542a41-0c1c-47cb-8ce1-4e85f89f2ae4</URL>
          </Citation>
          <Comment>The p.Val485fs (NM_004992) variant in MECP2 is predicted to cause a frameshift that results in a read-through of the stop codon (PVS1). The p.Val485fs variant in MECP2 has been reported as de novo occurrence in at least two individuals (biological parentage unconfirmed) with Rett Syndrome (PMID 11402105, Clinvar Variation ID: 143485) (PM6_strong). The p.Val485fs variant has been observed in at least 3 other individuals with Rett Syndrome (PMID 11402105, PMID 16473305, ClinVar) (PS4_moderate). The p.Val485fs variant in MECP2 is absent from gnomAD (PM2_supporting). The p.Val485fs variant in MECP2 has been reported in an individual with a clinical phenotype suggestive of Rett Syndrome (PMID 11402105) (PP4). In summary the p.Val485fs variant in MECP2 is classified as Pathogenic for Rett syndrome based on the ACMG/AMP criteria (PVS1, PM6_strong, PS4_moderate, PM2_supporting, PP4).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen RettAS ACMG Specifications V2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/bjzrjqbb/clingen_rettas_acmg_specifications_v2.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001110792.2(MECP2):c.1490_1493del</Name>
            <Name>p.Val497fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.11:g.154030373_154030376del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0010726" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11731976</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7905306" SubmissionDate="2024-01-17" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="2b25a547-31cf-4986-8974-e84c38965b32" localKeyIsSubmitted="1" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV004232288" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Centre for Population Genomics, CPG" OrgID="509293" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/2b25a547-31cf-4986-8974-e84c38965b32</URL>
          </Citation>
          <Comment>This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). This variant has been identified as a de novo occurrence in at least 2 individuals with Rett syndrome, without confirmation of paternity and maternity (PM6_Strong). (PMID 11402105, Clinvar Variation ID: 143485) Has been observed in at least 3 individuals with phenotypes consistent with MECP2-related disease(PS4_Moderate). (PubMed: 11402105â€š 16473305 , ClinVar 143485) This variant is absent from gnomAD (PM2_Supporting).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">McKnight et al. (Hum Mutat. 2022)</Attribute>
          <Citation>
            <ID Source="PubMed">34837432</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001110792.2(MECP2):c.1490_1493del</Name>
            <Name>p.Val497fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.11:g.154030373_154030376del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0010726" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14158224</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2371772" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4982920|MedGen:C1968556" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001206524" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20108430</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11402105</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473305</ID>
          </Citation>
          <Comment>This sequence change results in a frameshift in the MECP2 gene (p.Val485Alafs*26). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 2 amino acid(s) of the MECP2 protein and extend the protein by 23 additional amino acid residues. For these reasons, this variant has been classified as Pathogenic. This variant results in an extension of the MECP2 protein. Other variant(s) that result in a similarly extended protein product (p.Ser486Ilefs*27) have been observed in individuals with MECP2-related disease (PMID: 20108430). This suggests that these extensions may be clinically significant. ClinVar contains an entry for this variant (Variation ID: 143485). This frameshift has been observed in individual(s) with clinical features of MECP2-related conditions (PMID: 11402105, 16473305; Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.153295822_153295825del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1968556" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2371772" TraitType="Disease" MappingType="XRef" MappingValue="C1968556" MappingRef="MedGen">
        <MedGen CUI="C1968556" Name="Severe neonatal-onset encephalopathy with microcephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="310803" TraitType="Disease" MappingType="Name" MappingValue="Rett syndrome" MappingRef="Preferred">
        <MedGen CUI="C0035372" Name="Rett syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7905306" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0010726" MappingRef="MONDO">
        <MedGen CUI="C0035372" Name="Rett syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4970145" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0010726" MappingRef="MONDO">
        <MedGen CUI="C0035372" Name="Rett syndrome" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2018-06-25">SCV000219585</Accession>
        <Description>Gene is no longer tested by laboratory.</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

